Financhill
Sell
17

XRAY Quote, Financials, Valuation and Earnings

Last price:
$15.60
Seasonality move :
2.26%
Day range:
$14.91 - $15.59
52-week range:
$14.78 - $33.72
Dividend yield:
4.11%
P/E ratio:
--
P/S ratio:
0.83x
P/B ratio:
1.59x
Volume:
4.5M
Avg. volume:
2.8M
1-year change:
-52.82%
Market cap:
$3.1B
Revenue:
$3.8B
EPS (TTM):
-$4.55

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
XRAY
Dentsply Sirona
$920.3M $0.43 -10.31% 232.77% $20.20
ALGN
Align Technology
$999.2M $2.45 -1.71% 44.8% $254.64
BIOLQ
Biolase
$13.5M -$0.01 3.78% -99.71% $1.2000
MLSS
Milestone Scientific
$2.7M -$0.01 17.38% -66.67% --
NVST
Envista Holdings
$645.9M $0.22 -2.29% 51.15% $21.33
SONX
Sonendo
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
XRAY
Dentsply Sirona
$15.56 $20.20 $3.1B -- $0.16 4.11% 0.83x
ALGN
Align Technology
$166.20 $254.64 $12.2B 29.63x $0.00 0% 3.12x
BIOLQ
Biolase
$0.0089 $1.2000 $326.4K -- $0.00 0% 0.00x
MLSS
Milestone Scientific
$0.93 -- $72.1M -- $0.00 0% 8.17x
NVST
Envista Holdings
$16.65 $21.33 $2.9B -- $0.00 0% 1.15x
SONX
Sonendo
-- -- -- -- $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
XRAY
Dentsply Sirona
52.37% 0.344 56.57% 0.55x
ALGN
Align Technology
-- 2.453 -- 1.02x
BIOLQ
Biolase
142.17% 1.859 714.45% 0.23x
MLSS
Milestone Scientific
-- 2.706 -- 1.42x
NVST
Envista Holdings
32.21% 1.056 41.98% 1.63x
SONX
Sonendo
-- 0.000 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
XRAY
Dentsply Sirona
$446M $9M -18.42% -32.39% -56.02% $36M
ALGN
Align Technology
$696.9M $177.1M 11.12% 11.12% 17.79% $263.1M
BIOLQ
Biolase
$4.4M -$695K -129.74% -21668.17% -7.48% -$4.5M
MLSS
Milestone Scientific
$1.8M -$1.5M -61.33% -61.33% -58.44% -$973.9K
NVST
Envista Holdings
$372.5M $67.7M -22.7% -32.33% 7.11% $123.8M
SONX
Sonendo
-- -- -- -- -- --

Dentsply Sirona vs. Competitors

  • Which has Higher Returns XRAY or ALGN?

    Align Technology has a net margin of -47.51% compared to Dentsply Sirona's net margin of 10.43%. Dentsply Sirona's return on equity of -32.39% beat Align Technology's return on equity of 11.12%.

    Company Gross Margin Earnings Per Share Invested Capital
    XRAY
    Dentsply Sirona
    49.28% -$2.16 $4.1B
    ALGN
    Align Technology
    70.03% $1.39 $3.9B
  • What do Analysts Say About XRAY or ALGN?

    Dentsply Sirona has a consensus price target of $20.20, signalling upside risk potential of 28.54%. On the other hand Align Technology has an analysts' consensus of $254.64 which suggests that it could grow by 53.21%. Given that Align Technology has higher upside potential than Dentsply Sirona, analysts believe Align Technology is more attractive than Dentsply Sirona.

    Company Buy Ratings Hold Ratings Sell Ratings
    XRAY
    Dentsply Sirona
    2 11 0
    ALGN
    Align Technology
    9 5 0
  • Is XRAY or ALGN More Risky?

    Dentsply Sirona has a beta of 0.976, which suggesting that the stock is 2.383% less volatile than S&P 500. In comparison Align Technology has a beta of 1.687, suggesting its more volatile than the S&P 500 by 68.738%.

  • Which is a Better Dividend Stock XRAY or ALGN?

    Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.11%. Align Technology offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Align Technology pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XRAY or ALGN?

    Dentsply Sirona quarterly revenues are $905M, which are smaller than Align Technology quarterly revenues of $995.2M. Dentsply Sirona's net income of -$430M is lower than Align Technology's net income of $103.8M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Align Technology's PE ratio is 29.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.83x versus 3.12x for Align Technology. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XRAY
    Dentsply Sirona
    0.83x -- $905M -$430M
    ALGN
    Align Technology
    3.12x 29.63x $995.2M $103.8M
  • Which has Higher Returns XRAY or BIOLQ?

    Biolase has a net margin of -47.51% compared to Dentsply Sirona's net margin of -13.16%. Dentsply Sirona's return on equity of -32.39% beat Biolase's return on equity of -21668.17%.

    Company Gross Margin Earnings Per Share Invested Capital
    XRAY
    Dentsply Sirona
    49.28% -$2.16 $4.1B
    BIOLQ
    Biolase
    40.39% -$0.04 $12.4M
  • What do Analysts Say About XRAY or BIOLQ?

    Dentsply Sirona has a consensus price target of $20.20, signalling upside risk potential of 28.54%. On the other hand Biolase has an analysts' consensus of $1.2000 which suggests that it could grow by 22321.53%. Given that Biolase has higher upside potential than Dentsply Sirona, analysts believe Biolase is more attractive than Dentsply Sirona.

    Company Buy Ratings Hold Ratings Sell Ratings
    XRAY
    Dentsply Sirona
    2 11 0
    BIOLQ
    Biolase
    1 1 0
  • Is XRAY or BIOLQ More Risky?

    Dentsply Sirona has a beta of 0.976, which suggesting that the stock is 2.383% less volatile than S&P 500. In comparison Biolase has a beta of 0.817, suggesting its less volatile than the S&P 500 by 18.311%.

  • Which is a Better Dividend Stock XRAY or BIOLQ?

    Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.11%. Biolase offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Biolase pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XRAY or BIOLQ?

    Dentsply Sirona quarterly revenues are $905M, which are larger than Biolase quarterly revenues of $10.9M. Dentsply Sirona's net income of -$430M is lower than Biolase's net income of -$1.4M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Biolase's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.83x versus 0.00x for Biolase. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XRAY
    Dentsply Sirona
    0.83x -- $905M -$430M
    BIOLQ
    Biolase
    0.00x -- $10.9M -$1.4M
  • Which has Higher Returns XRAY or MLSS?

    Milestone Scientific has a net margin of -47.51% compared to Dentsply Sirona's net margin of -58.13%. Dentsply Sirona's return on equity of -32.39% beat Milestone Scientific's return on equity of -61.33%.

    Company Gross Margin Earnings Per Share Invested Capital
    XRAY
    Dentsply Sirona
    49.28% -$2.16 $4.1B
    MLSS
    Milestone Scientific
    73.05% -$0.02 $7.2M
  • What do Analysts Say About XRAY or MLSS?

    Dentsply Sirona has a consensus price target of $20.20, signalling upside risk potential of 28.54%. On the other hand Milestone Scientific has an analysts' consensus of -- which suggests that it could grow by 129.66%. Given that Milestone Scientific has higher upside potential than Dentsply Sirona, analysts believe Milestone Scientific is more attractive than Dentsply Sirona.

    Company Buy Ratings Hold Ratings Sell Ratings
    XRAY
    Dentsply Sirona
    2 11 0
    MLSS
    Milestone Scientific
    0 0 0
  • Is XRAY or MLSS More Risky?

    Dentsply Sirona has a beta of 0.976, which suggesting that the stock is 2.383% less volatile than S&P 500. In comparison Milestone Scientific has a beta of 1.409, suggesting its more volatile than the S&P 500 by 40.929%.

  • Which is a Better Dividend Stock XRAY or MLSS?

    Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.11%. Milestone Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Milestone Scientific pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XRAY or MLSS?

    Dentsply Sirona quarterly revenues are $905M, which are larger than Milestone Scientific quarterly revenues of $2.5M. Dentsply Sirona's net income of -$430M is lower than Milestone Scientific's net income of -$1.5M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Milestone Scientific's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.83x versus 8.17x for Milestone Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XRAY
    Dentsply Sirona
    0.83x -- $905M -$430M
    MLSS
    Milestone Scientific
    8.17x -- $2.5M -$1.5M
  • Which has Higher Returns XRAY or NVST?

    Envista Holdings has a net margin of -47.51% compared to Dentsply Sirona's net margin of 0.18%. Dentsply Sirona's return on equity of -32.39% beat Envista Holdings's return on equity of -32.33%.

    Company Gross Margin Earnings Per Share Invested Capital
    XRAY
    Dentsply Sirona
    49.28% -$2.16 $4.1B
    NVST
    Envista Holdings
    57.05% $0.01 $4.3B
  • What do Analysts Say About XRAY or NVST?

    Dentsply Sirona has a consensus price target of $20.20, signalling upside risk potential of 28.54%. On the other hand Envista Holdings has an analysts' consensus of $21.33 which suggests that it could grow by 28.13%. Given that Dentsply Sirona has higher upside potential than Envista Holdings, analysts believe Dentsply Sirona is more attractive than Envista Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    XRAY
    Dentsply Sirona
    2 11 0
    NVST
    Envista Holdings
    3 10 1
  • Is XRAY or NVST More Risky?

    Dentsply Sirona has a beta of 0.976, which suggesting that the stock is 2.383% less volatile than S&P 500. In comparison Envista Holdings has a beta of 1.326, suggesting its more volatile than the S&P 500 by 32.59%.

  • Which is a Better Dividend Stock XRAY or NVST?

    Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.11%. Envista Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Envista Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XRAY or NVST?

    Dentsply Sirona quarterly revenues are $905M, which are larger than Envista Holdings quarterly revenues of $652.9M. Dentsply Sirona's net income of -$430M is lower than Envista Holdings's net income of $1.2M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Envista Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.83x versus 1.15x for Envista Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XRAY
    Dentsply Sirona
    0.83x -- $905M -$430M
    NVST
    Envista Holdings
    1.15x -- $652.9M $1.2M
  • Which has Higher Returns XRAY or SONX?

    Sonendo has a net margin of -47.51% compared to Dentsply Sirona's net margin of --. Dentsply Sirona's return on equity of -32.39% beat Sonendo's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    XRAY
    Dentsply Sirona
    49.28% -$2.16 $4.1B
    SONX
    Sonendo
    -- -- --
  • What do Analysts Say About XRAY or SONX?

    Dentsply Sirona has a consensus price target of $20.20, signalling upside risk potential of 28.54%. On the other hand Sonendo has an analysts' consensus of -- which suggests that it could fall by --. Given that Dentsply Sirona has higher upside potential than Sonendo, analysts believe Dentsply Sirona is more attractive than Sonendo.

    Company Buy Ratings Hold Ratings Sell Ratings
    XRAY
    Dentsply Sirona
    2 11 0
    SONX
    Sonendo
    0 0 0
  • Is XRAY or SONX More Risky?

    Dentsply Sirona has a beta of 0.976, which suggesting that the stock is 2.383% less volatile than S&P 500. In comparison Sonendo has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock XRAY or SONX?

    Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.11%. Sonendo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Sonendo pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XRAY or SONX?

    Dentsply Sirona quarterly revenues are $905M, which are larger than Sonendo quarterly revenues of --. Dentsply Sirona's net income of -$430M is higher than Sonendo's net income of --. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Sonendo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.83x versus -- for Sonendo. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XRAY
    Dentsply Sirona
    0.83x -- $905M -$430M
    SONX
    Sonendo
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Is Ford Stock Undervalued Amid the EV Transition?
Is Ford Stock Undervalued Amid the EV Transition?

There is a lot going on in the electric vehicle…

Is Goldman Sachs Stock a Buy Sell or Hold?
Is Goldman Sachs Stock a Buy Sell or Hold?

When the Federal Reserve started hiking rates in 2022, banks’…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Sell
49
SMTC alert for Mar 17

Semtech [SMTC] is down 0.49% over the past day.

Buy
62
PLPC alert for Mar 17

Preformed Line Products [PLPC] is up 3.8% over the past day.

Sell
50
NUTX alert for Mar 17

Nutex Health [NUTX] is up 4.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock